Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK - Get Free Report) Director Susan Swanezy sold 15,700 shares of the stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $63.80, for a total transaction of $1,001,660.00. Following the completion of the sale, the director owned 28,934 shares of the company's stock, valued at approximately $1,845,989.20. The trade was a 35.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Vivmark Residential Common Shares of Beneficial Interest Stock Up 0.6%
NYSE VMRK traded up $0.38 during trading on Wednesday, reaching $64.41. 6,131,899 shares of the company traded hands, compared to its average volume of 4,406,111. The company has a current ratio of 0.19, a quick ratio of 0.19 and a debt-to-equity ratio of 0.77. Vivmark Residential Common Shares of Beneficial Interest has a 1-year low of $57.57 and a 1-year high of $71.50. The company has a market capitalization of $24.15 billion, a price-to-earnings ratio of 15.77, a PEG ratio of 5.37 and a beta of 0.73.
Trending Headlines about Vivmark Residential Common Shares of Beneficial Interest
Here are the key news stories impacting Vivmark Residential Common Shares of Beneficial Interest this week:
- Positive Sentiment: Stifel Nicolaus maintained a “buy” rating and trimmed its price target only slightly, from $79.00 to $78.50. The target remains well above the recent trading level, signaling continued confidence in Vivmark’s potential. Benzinga article
- Positive Sentiment: Evercore initiated coverage with an “in-line” rating and a $72.00 price target. Although not an outright bullish rating, the target indicates potential appreciation and adds institutional research coverage. Tickerreport article
- Positive Sentiment: Zacks Research raised its FY2026 EPS forecast from $4.06 to $4.07, FY2027 EPS from $4.20 to $4.21, and Q1 2027 EPS from $1.00 to $1.02. These increases suggest slightly improved expectations for near- and medium-term profitability.
- Neutral Sentiment: The analyst consensus still projects steady earnings progression, including approximately $4.40 in FY2028 EPS, but the revisions are small and do not represent a major change to Vivmark’s outlook.
- Negative Sentiment: Zacks lowered estimates for Q3 2026, Q2 2027, Q3 2027, Q1 2028, and FY2028. The FY2028 forecast declined from $4.43 to $4.40, indicating modest pressure on longer-term earnings expectations.
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on the company. Evercore assumed coverage on Vivmark Residential Common Shares of Beneficial Interest in a research note on Tuesday. They set an "in-line" rating and a $72.00 price objective on the stock. Stifel Nicolaus reduced their target price on shares of Vivmark Residential Common Shares of Beneficial Interest from $79.00 to $78.50 and set a "buy" rating for the company in a research report on Wednesday. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $75.25.
View Our Latest Stock Analysis on Vivmark Residential Common Shares of Beneficial Interest
About Vivmark Residential Common Shares of Beneficial Interest
(
Get Free Report)
Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, DC, Seattle, San Francisco, Southern California and Denver.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Vivmark Residential Common Shares of Beneficial Interest, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vivmark Residential Common Shares of Beneficial Interest wasn't on the list.
While Vivmark Residential Common Shares of Beneficial Interest currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.